RxDoctor Payments DataLook up a doctor →

Matthew Smith, MD

Family Medicine · Waterloo, IANPI 1609876507

Payments from drug & device makers

$25,358in general payments, 2019–2025

Across 1,523 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • AbbVie$3K
  • Pfizer$3K
  • Amgen$2K
  • Lilly USA, LLC$2K
  • Boehringer Ingelheim$1K
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)162$3,771
AbbVie(2 entities)202$3,104
Pfizer179$2,789
Amgen(2 entities)132$1,768
Lilly USA, LLC126$1,693
Boehringer Ingelheim75$1,303
GSK106$1,198
Novo Nordisk65$1,119
Johnson & Johnson(2 entities)52$1,114
Novartis38$631
E.r. Squibb & Sons, L.L.C.35$568
Mylan Specialty L.p.29$509
Phathom Pharmaceuticals, Inc.18$502
Exact Sciences21$345
Kowa Pharmaceuticals America, Inc.26$332
Bayer17$329
Axsome Therapeutics, Inc.12$303
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)13$297
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$281
Sanofi-aventis U.S. LLC14$216
Harmony Biosciences LLC11$208
Radius Health, Inc.12$205
Merck20$196
Viatris Specialty LLC7$192
Sunovion Pharmaceuticals Inc.13$177
Esperion Therapeutics, Inc.10$171
Takeda Pharmaceuticals U.S.A., Inc.12$168
Otsuka America Pharmaceutical, Inc.7$167
Astellas Pharma US Inc8$138
Biohaven Pharmaceuticals, Inc.5$130
Medicure Pharma Inc.1$113
Biohaven Pharmaceutical Holding Company Ltd.5$103
Vertex5$103
Tolmar, Inc.5$95
Ironwood Pharmaceuticals, Inc5$94
Idorsia Pharmaceuticals US Inc6$86
Regeneron Healthcare Solutions, Inc.4$69
Boston Scientific4$68
Amarin Pharma, Inc.3$62
Ironshore Pharmaceuticals Inc.3$53
Eisai Inc.4$50
Actelion Pharmaceuticals US, Inc.2$46
Sumitomo Pharma America, Inc.3$44
Shire North American Group Inc3$41
Almatica Pharma LLC2$40
Supernus Pharmaceuticals, Inc.3$36
Collegium Pharmaceutical, Inc.2$32
Xeris Pharmaceuticals, Inc.2$32
Corium, LLC2$31
Adlon Therapeutics L.p.2$30
Scynexis, Inc.1$29
Laborie Medical Technologies Corp.1$23
Exeltis, USA Inc.1$19
Convatec Inc.1$19
Ardelyx, Inc.1$18
Teva Pharmaceuticals USA, Inc.1$18
Jazz Pharmaceuticals Inc.1$15
Bausch Health US, LLC1$15
Urovant Sciences Inc1$14
Shield Therapeutics Inc1$13

How this compares

$25,358 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa →

Medicare billing

Part B allowed, 2024
$214,651
Medicare patients
389
Services billed
2,747

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Waterloo

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →